Loading...
PhD Simona Kranjc Brezar

PhD Simona Kranjc Brezar
no.: 19058 source: ARIS

researcher – active in research organisation
Phone number (01) 587 96 07
E-mail skranjcat signonko-i.si
Foreign language skills
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Keywords
Experimental oncology, tumor biology, radiation, chemotherapy,electrochemotherapy
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
639.73
A''
0
A'
227.81
A1/2
345.38
CI10
835
CImax
94
h10
14
A1
2.09
A3
3.85
Data for the last 5 years (citations for the last 10 years) on February 21, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 76  1,393  868  11.42 
Scopus 77  1,665  1,092  14.18 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Tanja Jesenko  Bologna doctoral studies  11/1/2010 - 4/30/2014  33227 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Biology  SI University of Ljubljana, Biotechnical Faculty 1998 
Master's degree  M. Sc.     SI University of Ljubljana, Faculty of Medicine 2001 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 2003 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Title ecris.org.employ_rolegroup
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research  11/1/1998      Researcher 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,158 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,857 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,792 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,043 
5. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   2023 - 2024  PhD Matej Reberšek  3,423 
6. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,423 
7. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,872 
8. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  5,983 
9. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,687 
10. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2023  PhD Boštjan Markelc  3,290 
11. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,444 
12. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,217 
13. J1-6744  Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis   2014 - 2017  PhD Tina Kosjek  4,763 
14. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,039 
15. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,665 
16. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,222 
17. J3-4211  Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems   2011 - 2014  PhD Gregor Serša  6,391 
18. J1-4044  Apoptotic effects of alkylpyridinium compounds on lung adenocarcinoma cells   2011 - 2014  PhD Tom Turk  6,207 
19. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,786 
20. J1-4131  Synthesis, characterisation and use of novel ruthenium compounds in electrochemotherapy of tumors   2011 - 2014  PhD Iztok Turel  5,866 
21. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   2002 - 2005  PhD Maja Čemažar  4,800 
22. J3-3489  New biomedical applications of electroporation   2002 - 2004  PhD Gregor Serša  4,016 
23. J3-2049  Uporaba elektroporacij v genski terapiji (Slovene)   2000 - 2002  PhD Maja Čemažar  4,072 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,885 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,219 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2009 - 2014  PhD Gregor Serša  3,969 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   2004 - 2008  PhD Gregor Serša  3,043 
Views history
Favourite